Pharmaceutical

Recursion and Exscientia merge to form drug discovery company

Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.

Aug 11, 2024 - 04:00
Recursion and Exscientia merge to form drug discovery company
Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.
Read the original article

Tags:

Previous Article

Momentum Biotechnologies and Cube Biotech link for therapeutic solutions

Next Article

Brain electrical stimulation suppresses appetite. A new frontier in obesity trea...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Exodus of life scientists from academia reaches historic levels, new data show

Exodus of life scientists from academia reaches histori...

Sep 28, 2023

Lisata clinches rare disease status for osteosarcoma drug

Lisata clinches rare disease status for osteosarcoma drug

Mar 24, 2024

STAT+: FDA withdraws approval of controversial drug to prevent preterm births

STAT+: FDA withdraws approval of controversial drug to ...

Apr 7, 2023